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ADAR2 catalyses the deamination of adenosine to inosine
at the GluR2 Q/R site in the pre-mRNA encoding the
critical subunit of AMPA receptors. Among ADAR2 sub-
strates this is the vital one as editing at this position is
indispensable for normal brain function. However, the
regulation of ADAR2 post-translationally remains to be
elucidated. We demonstrate that the phosphorylation-de-
pendent prolyl-isomerase Pin1 interacts with ADAR2 and
is a positive regulator required for the nuclear localization
and stability of ADAR2. Pin1
 /  mouse embryonic ﬁbro-
blasts show mislocalization of ADAR2 in the cytoplasm
and reduced editing at the GluR2 Q/R and R/G sites. The
E3 ubiquitin ligase WWP2 plays a negative role by binding
to ADAR2 and catalysing its ubiquitination and subse-
quent degradation. Therefore, ADAR2 protein levels and
catalytic activity are coordinately regulated in a positive
manner by Pin1 and negatively by WWP2 and this may
have downstream effects on the function of GluR2. Pin1
and WWP2 also regulate the large subunit of RNA Pol II,
so these proteins may also coordinately regulate other key
cellular proteins.
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Introduction
The AMPA class of glutamate-gated ion channel receptors
(GluR) are impermeable to calcium if a GluR2 subunit is
present in the tetrameric receptor (Hollmann et al, 1991;
Verdoorn et al, 1991). This impermeability to calcium results
from RNA editing of the GluR2 transcript. The enzyme that
catalyses this RNA editing event is a member of the family of
adenosine deaminases that act on RNA (ADARs). ADAR2
speciﬁcally deaminates an adenosine residue in a glutamine
(Q) codon to an inosine that is read as guanosine by reverse
transcriptase and the translational machinery. ADAR2 con-
verts the glutamine (Q) codon to an arginine (R) codon with
100% efﬁciency at the GluR2 Q/R site changing a key residue
in the ion channel pore and rendering AMPA receptors
assembled with this subunit impermeable to calcium
(Sommer et al, 1991). The editing event also regulates
AMPA receptor assembly, slowing the passage of the GluR2
subunit through the ER thus ensuring correct receptor as-
sembly (Greger et al, 2003). Failure of RNA editing at this site
can lead to neuronal cell death due to the inﬂux of calcium
(Higuchi et al, 2000). A decrease in editing at this site has
been reported in sporadic ALS motor neurons (Kawahara
et al, 2004) and in hippocampal neurons following transient
forebrain ischaemia in a rat model of stroke (Peng et al,
2006).
Mice that are null mutants for ADAR2 are seizure-prone
and die within 3 weeks after birth (Higuchi et al, 2000).
Lethality in these Adar2
 /  mice can be rescued by knocking-
in the edited isoform of GluR2 (GluR2
R). This experiment
suggests that despite ADAR2 having other transcripts that it
edits, the critical site is the Q/R site in GluR2 transcripts.
These rescued mice have a normal phenotype, suggesting
that the unedited GluR2 isoform does not have an essential
biological function.
For this deamination event to occur, ADAR2 must recog-
nize and bind to double-stranded (ds)RNA that is formed at
the editing site between the edited exon and the downstream
intron (Higuchi et al, 1993). Identiﬁed transcripts edited
speciﬁcally by ADAR2 are mostly expressed in the CNS
even though the protein is also expressed in other tissues.
RNA editing occurs before splicing and ADAR2 localizes to
the nucleus. In some cells, ADAR2 accumulates within the
nucleolus (Desterro et al, 2003; Sansam et al, 2003); however,
this localization is dynamic. When transcripts that can be
edited are overexpressed in these cells, ADAR2 relocalizes to
the nucleoplasm (Desterro et al, 2003).
Until now the only regulator found to inﬂuence ADAR2
expression is CREB, which can induce ADAR2 expression in
hippocampal CA1 neurons in rat brain (Peng et al, 2006). In
this study, we demonstrate that ADAR2 is dynamically regu-
lated post-translationally by the phosphorylation-dependent
peptidyl-prolyl cis/trans isomerase Pin1 (peptidyl-prolyl iso-
merase NIMA interacting protein 1). Pin1 binds to a phos-
phorylated serine or threonine residue preceding a proline
residue and catalyses the cis/trans isomerization of the
peptide bond (Lu et al, 1999). This conformational change
can have a range of consequences on the function of target
proteins, altering catalytic activity, stability or subcellular
localization (for review see Lu and Zhou, 2007). Pin1 binds
to the amino-terminus of ADAR2 in a phosphorylation-de-
pendent manner. In the absence of Pin1, ADAR2 protein is
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4211more labile and is mislocalized to the cytoplasm, where it is
unable to edit pre-mRNAs and there is a decrease in editing of
the Q/R and R/G sites in endogenous GluR2 transcripts. Pin1
is therefore a positive regulator of ADAR2 editing activity.
We also identify a negative regulator of ADAR2 activity,
which is WWP2; a HECT (homologous to the E6-AP C
terminus) E3 ubiquitin ligase (Pirozzi et al, 1997). WWP2
binds to a conserved PPxY motif in ADAR2 and this interac-
tion results in ubiquitination and subsequent degradation of
ADAR2. An increase in the expression of WWP2 results
in a decrease in ADAR2 protein level. This report of the
post-translational regulation of ADAR2 demonstrates how
RNA editing activity is controlled by coordinate action of
two regulators.
Results
Phosphorylation sites near the N-terminus of ADAR2
When human ADAR2 was puriﬁed to homogeneity from
HeLa cells, enzymatic activity was very labile (O0Connell
et al, 1997). However, recombinant human ADAR2 protein
puriﬁed after overexpression in the yeast Pichia pastoris is
active and stable. To determine if the protein is regulated by
post-translational modiﬁcation, we performed mass spectro-
metry on recombinant ADAR2 puriﬁed from P. pastoris and
identiﬁed two phosphorylated serines near the amino-termi-
nus, serine (S) 26 and S31 (Supplementary Figure S1).
Phosphorylation at S26 has been independently veriﬁed
(Dephoure et al, 2008). The amino-terminal region of
ADAR2 is of interest since it has been shown to be important
for dimerization of the protein and autoinhibition of catalytic
activity (Gallo et al, 2003; Macbeth et al, 2004).
ADAR2 interacts with Pin1
The phosphorylated residues near the N-terminus of ADAR2
are within potential recognition motifs (Ser/Thr-Pro) for the
phosphorylation-dependent peptidyl-prolyl cis/trans isomer-
ase Pin1, a well-conserved and extremely efﬁcient enzyme for
transducing post-translational modiﬁcations into conforma-
tional changes in key cellular proteins (Lu and Zhou, 2007).
To determine whether Pin1 interacts with ADAR2, HEK293T
cells were transiently transfected with a construct expressing
ADAR2 bearing a FLAG epitope tag at the N-terminus and
tetra-His tag at the C-terminus. After 24h, the cells were
harvested, whole cell protein extracts were immunoprecipi-
tated with anti-FLAG monoclonal antibody and analysed by
immunoblot detection of the immunoprecipitate with mouse
anti-mitotic phosphoprotein monoclonal-2 (MPM-2) antibody
(Davis et al, 1983), that recognizes the phosphorylated Pin1
motif (Ser/Thr-Pro) in proteins. As shown in Figure 1A,
a-MPM-2 recognizes the FLAG-tagged ADAR2 protein. We
mutated T32, as this is the residue that precedes the proline
so it may be important for Pin1 binding. When the immuno-
precipitation was repeated with alanine (A) substitutions for
S26, S26/31 or T32 at the amino-terminus, the antibody
recognized ADAR2 less efﬁciently and loss of binding of the
MPM-2 antibody was particularly evident with the triple
mutant ADAR2
S26A/S31A/T32A (Figure 1A), suggesting that
the amino-terminus of ADAR2 harbours phosphorylated S/
T-P sites at the amino-terminus that are likely to bind Pin1.
The ability of ADAR2 to bind to Pin1 was next evaluated by
in vitro binding assays with GST–Pin1 and recombinant
ADAR2 puriﬁed from P. pastoris. As shown in Figure 1B
(left panel), ADAR2 binds strongly to GST–Pin1 whereas
ADAR2 did not interact with the GST beads alone. To map
the interaction between Pin1 and ADAR2, ADAR2
S26A,
ADAR2
S26A/S31A/T32A or an N-terminal deletion of ADAR2
from amino acid to 4–72 (Wong et al, 2003) were puriﬁed
from P. pastoris (Figure 1B, right panel) and similarly tested
for interaction with GST–Pin1. The interaction of GST–Pin1
with ADAR
S26A was slightly weaker than with wild-type
ADAR2 and interaction was drastically decreased with the
triple mutant ADAR2
S26A/S31A/T32A, and totally absent with
ADAR2
D4–72 (Figure 1B, left panel). To determine if the
interaction with Pin1 depends on ADAR2 phosphorylation,
a transient transfection of ADAR2 into HEK293T cells was
performed and the lysate was treated with l phosphatase
followed by a pull-down assay with GST–Pin1 beads. The
interaction between ADAR2 and Pin1 was observed and this
was abolished with a longer l phosphatase treatment
(Figure 1C).
As these experiments were performed in vitro, we then
analysed the Pin1 ADAR2 interaction in HEK293T cells by
transiently cotransfecting with constructs expressing FLAG-
tagged ADAR2 and HA-tagged Pin1. The cells were harvested
after 24h and an immunoprecipitation of the lysate was
performed with anti-FLAG monoclonal antibody and the
precipitate was detected on an immunoblot with an anti-HA
antibody (Figure 1D). Only the wild-type ADAR2 interacted
with HA-tagged Pin1. Neither the triple alanine mutant nor
ADAR2
D4–72 interacted with Pin1. In addition, ADAR2 that
has mutations in both RNA-binding domains and cannot bind
to dsRNA (ADAR2
RRM1–2) (Valente and Nishikura, 2007) does
not interact with Pin1. Therefore, ADAR2 has to bind to RNA
before it can interact with Pin1. In the in vitro binding assays
with GST–Pin1 and recombinant ADAR2 puriﬁed from
P. pastoris (Figure 1B), ADAR2 appears to interact with
GST–Pin1 in the absence of dsRNA. However in our experi-
ence, it is difﬁcult to eliminate all the dsRNA present in the
puriﬁed protein fraction from yeast (Gallo et al, 2003) so
therefore we presume that this in vitro reaction is also
mediated by dsRNA. Similar results were obtained when
HEK293T cells were transiently transfected with FLAG–
ADAR2 followed by coimmunoprecipitation with endogenous
Pin1 (Figure 1E). These results demonstrate that Pin1 binds
to ADAR2 in a phosphorylation-dependent manner and that
this interaction occurs at the amino-terminal of ADAR2 after
it has bound to RNA.
Pin1 expression is required for optimal editing at the
GluR2 Q/R site
Since ADAR2 converts a glutamine (Q) codon to an arginine
(R) codon with 100% efﬁciency at the GluR2 Q/R site in
neurons, the important question is whether the interaction
between Pin1 and ADAR2 affects editing activity at the critical
GluR2 Q/R site. To address this point, we analysed editing of
the GluR2 Q/R site in HeLa cells. To increase the level of
editing at the Q/R site by ADAR2 in HeLa cells, we transiently
cotransfected a plasmid encoding ADAR2 with the GluR2 B13
minigene. The level of editing rose to 100%. We then co-
transfected an siRNA speciﬁc for Pin1 and editing fell to 53%
(Figure 2A).
We also analysed editing at the Q/R site in the GluR2 B13
minigene transcript (Higuchi et al, 1993) by endogenous
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however, when siRNA speciﬁc for Pin1 was cotransfected, the
level of editing fell to 46% (Figure 2B). Editing was restored
to 74% when Pin1 was overexpressed in HeLa cells.
We also examined the effect of reducing Pin1 expression
on editing of endogenously expressed GluR2 transcript in a
neuroblastoma cell line, SH-SY5Y (Figure 2C). In this cell
line, ADAR2 was cotransfected with either a Pin1-speciﬁc
siRNA or a control siRNA and editing of the endogenous
GluR2 transcript was analysed. Again the level of editing
dropped from 100% to B60% at the Q/R site when there was
a reduction in Pin1 expression. We also analysed editing at
the R/G site in the GluR2 transcript and found it was 69% but
dropped to 45% when siRNA speciﬁc for Pin1 was cotrans-
fected whereas editing was 73% when a control siRNA was
cotransfected. The reduction in Pin1 expression for this
experiment is shown in Supplementary Figure S2.
To examine the effect of complete Pin1 elimination, we
cotransfected constructs expressing the GluR2 B13 minigene
and ADAR2 into an immortalized mouse ﬁbroblast cell line
derived from Pin1
 /  mice (Figure 2D) (Fujimori et al, 1999).
The editing activity at the Q/R site was B50% and increased
to 100% when a construct expressing Pin1 was reintroduced
in these cells. All these experiments strongly suggest that
ADAR2 requires Pin1 for maximal editing of the critical
Q/Rand R/G sites in GluR2 transcripts.
Pin1 has a role in the nuclear localization of ADAR2
Pin1 has many diverse activities within the cell and it can
alter the cellular localization of its substrate, as occurs with
b-catenin (Ryo et al, 2001). Although ADAR2 has been
documented as nuclear, recent evidence demonstrated that
in human motor neurons in spinal cord sections, ADAR2
is both nuclear and cytoplasmic (Aizawa et al, 2010).
Interestingly, a deletion of the amino-terminal residues 4–72
renders ADAR2 cytoplasmic (Wong et al, 2003) and it has also
been demonstrated that this region is required for nuclear
localization as it contains a non-canonical NLS within the
Figure 1 The amino-terminus of ADAR2 harbours a Pin1-binding site. (A) The anti-MPM-2 antibody recognizes potential Pin1 sites in ADAR2
puriﬁed after overexpression in P. pastoris. Immunoblot analysis with anti-MPM-2 antibody of anti-FLAG immunoprecipitates from lysates of
HEK293T cells transfected with FLAG-tagged hADAR2, ADAR2
S26A/S31A, ADAR2
S26A/S31A/T32A, ADAR2
S26A, ADAR2
T32A or pcD3. The minor
band in the lane with pcD3 is contamination from the neighbouring lane. ADAR input visualized with anti-FLAG antibody, lower panel.
(B) Puriﬁed ADAR2 binds in vitro to Pin1 immobilized on beads. (Upper left panel) Immunoblot analysis with anti-FLAG antibody of the
binding of FLAG-tagged ADAR2, ADAR2
S26A, ADAR2
S26A/S31A/T32A, ADAR2
D4–72 bound to GST–Pin1 or GST on glutathione beads. (Lower
panel) GST input visualized with anti-GST antibody. (Right panel) Puriﬁed ADAR proteins stained with Coomassie. (C) Binding of puriﬁed
ADAR2 to Pin1 depends on phosphorylation of Pin1 sites on ADAR2. l phosphatase treatment of lysate from HEK293Tcells transfected with
ADAR2 for 0 ( ), 2h (þ), 3h (þþ) prior to incubation with GST–Pin1. Immunoblot analysis of ADAR2 with anti-FLAG antibody. Middle and
lower panels are input loading controls. (D) Pin1 binds to ADAR2 in HEK293T cells. Coimmunoprecipitation of ADAR2 and Pin1 performed
with anti-FLAG antibody on HEK293T cell lysate cotransfected with HA–Pin1 and either FLAG-tagged ADAR2, ADAR2
D4–72, ADAR2
RRM1–2,
ADAR2
S26A/S31A/T32A or pcD3. HA–Pin1 was detected with anti-HA antibody. Asterisks represent IgG light chain. (Lower panel) Immunoblot of
input proteins with anti-FLAG antibody. (E) Endogenous Pin1 detected with anti-Pin1 antibody after immunoprecipitation with anti-FLAG
antibody from cell lysates of HEK293Tcells transfected with FLAG-tagged ADAR2, ADAR2
S26A/S31A/T32A, ADAR2
D4–72, ADAR2
RRM1–2 or pcD3.
(Lower panel) Immunoblot of input proteins detected with anti-FLAG antibody. Asterisks represent IgG light chain.
Pin1 and WWP2 regulate ADAR2
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removes the Pin1-binding site, we wondered if preventing
Pin1 binding also leads to mislocalization of ADAR2. To
elucidate this we transiently transfected GFP-tagged ADAR2
into Pin1
þ/þ and Pin1
 /  MEF cells and performed immu-
noﬂuorescence detection of ADAR2 (Figure 3A). In the ab-
sence of Pin1, wild-type ADAR2 is mislocalized in the
cytoplasm (Figure 3A, lower panel). Mislocalization of
ADAR2 is conﬁrmed when nuclear and cytoplasmic fractio-
nation is performed on Pin1
 /  MEF cells transiently trans-
fected with FLAG-tagged ADAR2 (Figure 3D). When Pin1 was
reintroduced into these cells, the level of ADAR2 in the
cytoplasm was signiﬁcantly reduced (Figure 3B and D).
This effect of Pin1 on the localization of ADAR2 requires
Pin1 prolyl-isomerase enzymatic activity as a Pin1
S67E mutant
that is catalytically inactive was unable to restore ADAR2
localization to the nucleus (Figure 3C). GFP–ADAR2 is loca-
lized to the nucleus when Pin1 is present; however, cyto-
plasmic localization of GFP–ADAR2 increases following
cotransfection with catalytically inactive Pin1. Increased
FLAG–ADAR2 is also observed in the cytoplasmic fraction
of Pin1
 /  MEF cells transiently transfected with FLAG-
tagged ADAR2 (Figure 3D).
As Pin1 recognizes a phosphorylated serine or threonine
preceding a proline, we replaced the phosphorylated amino
acids as well as the prolines with alanine to determine if all
were required for nuclear localization. As expected, the triple
mutant FLAG–ADAR2
S26/S31A/T32A was present in the cyto-
plasm (Supplementary Figure S3) and this appears slightly
different to ADAR2
D4–72 that is more localized around the
nuclear periphery (Supplementary Figure S4). When the
proline mutants were generated; FLAG–ADAR2
P27A and
FLAG–ADAR2
P33A, were transiently transfected into HeLa
cells together with HA–Pin1 (Figure 4), FLAG–ADAR2
P33A
was present in the cytoplasm as detected by immunoﬂuores-
cence as well as by nuclear and cytoplasmic fractionation
(Figure 4B and C) whereas FLAG–ADAR2
P27A is nuclear. This
implies that the second proline is the critical one, thus the
phosphorylation of T32 may be the critical site for Pin1
binding and P33 for isomerization. Notably, this is also the
most conserved Pin1 site in vertebrate ADAR2 sequences
(Supplementary Figure S1).
Pin1 stabilizes ADAR2
We wanted to elucidate if Pin1 had other effects on ADAR2.
As Pin1 has been shown to inﬂuence the stability of proteins
such as b-catenin (Ryo et al, 2001), NF-kB( R y oet al, 2003)
and p53 (Zacchi et al, 2002; Zheng et al, 2002), we wondered
if Pin1 also inﬂuences the stability of ADAR2. The level of
Pin1 was reduced in HeLa cells by transfecting either pSuper
Figure 2 Pin1 is required for efﬁcient editing at the GluR2 Q/R site. (A) DNA sequence chromatograph of the RT–PCR product of the region
encompassing the Q/R site (arrow) encoded by the GluR2 B13 minigene transiently cotransfected with ADAR2 (2mg) in HeLa cells, editing is
100% (left chromatograph). Editing of the Q/R site drops to 53% when an siRNA speciﬁc for Pin1 is cotransfected together with plasmids
encoding both ADAR2 and the GluR2 B13 minigene (middle chromatograph). Editing is 100% at the GluR2 Q/R site when a control siRNA is
cotransfected (right chromatograph). Immunoblot analysis of cell lysate from HeLa cells with either anti-Pin1 or anti-tubulin antibodies (right
panel). (B) (Left panel) Sequencing chromatogram of editing by endogenous ADAR2 at the Q/R site of RT–PCR product pools from the GluR2
B13 minigene transcript that has been transiently transfected into HeLa cells. Arrows indicate Q/R editing site in all panels. Immunoblot
analysis with anti-Pin1 antibody of HeLa cell extracts that have been cotransfected with GFP in the presence of either Pin1-speciﬁc siRNA, no
siRNA or HA–Pin1 construct (0.5mg). Proteins are detected with anti-Pin1 antibody and anti-GFP antibody as a loading control (right panel).
(C) Chromatograph of editing of endogenous GluR2 transcript at the Q/R site in neuroblastoma SH-SY5Y cells transfected with ADAR2 (2mg).
Editing is 100% at the Q/R site (left chromatograph). A decrease in editing is observed when an siRNA speciﬁc for Pin1 was cotransfected
(middle chromatograph). A control siRNA does not affect editing when transfected (right chromatograph). Arrows indicate the Q/R site. Cell
lysates of SH-SY5Y cells were analysed by immunoblot with either anti-Pin1 or anti-tubulin (right panel). (D) Chromatograph of editing at the
Q/R site of GluR2 B13 minigene transcript in Pin1
 /  MEF cells transfected with ADAR2 (2mg). Editing increased to 100% when Pin1
 /  MEF
cells were cotransfected with either 0.5 or 1mg of a construct expressing Pin1. An arrow marks the Q/R editing site in all the chromatographs.
Pin1 and WWP2 regulate ADAR2
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siRNA so that the level of endogenous ADAR2 could be
analysed (Figure 5A). A similar experiment was performed
in the neuroblastoma cell line SH-SY5Y (Figure 5C). Twenty-
four hours after transfection, cycloheximide was added to
prevent further protein synthesis, a time course from 0 to 8h
was performed to chase the decay of ADAR2 protein and the
samples were analysed by immunoblot analysis to determine
ADAR2 levels. In both cell lines, the protein level of ADAR2
decreased when cycloheximide was added; however, the
decrease was more dramatic when Pin1 expression was
reduced (Figure 5A–C). The stability of the triple mutant
ADAR2
S26A/S31A/T32A was also analysed after cycloheximide
treatment (Figure 5D). As predicted this mutant protein was
unstable as it could no longer interact with Pin1. Therefore,
Pin1 affects the stability of ADAR2.
The E3 ubiquitin ligase WWP2 interacts with ADAR2
Mass spectrometry was performed on the original samples of
ADAR2 puriﬁed from large quantities of HeLa cell nuclear
fractions (O0Connell et al, 1997) and one of the proteins that
copuriﬁed with ADAR2 was WWP2, an E3 ubiquitin ligase
containing four WW domains as well as a HECT domain.
As ADAR2 was unstable in the absence of Pin1, we wondered
if this E3 ligase was involved. WWP2 can bind directly
to a PPxY motif within its substrate. Analysis of the
ADAR2 amino-acid sequence revealed that this motif
was present twice, at the amino-terminus and carboxyl-
terminus of ADAR2 and was highly conserved (Supple-
mentary Figure S5).
To demonstrate that ADAR2 and WWP2 interact, HEK293T
cells were transiently cotransfected with constructs expres-
sing FLAG–ADAR2 and WWP2 with a c-myc epitope tag at
its amino-terminus. An immunoprecipitation was performed
with anti-FLAG monoclonal antibody to precipitate FLAG–
ADAR2 and c-myc–WWP2 was present in this precipitate
(Figure 6A). To determine which motif in ADAR2 WWP2
binds to, transient transfections were performed in HEK293T
cells with constructs expressing full-length and truncated
forms of ADAR2 all with FLAG epitope at their amino-
terminus. Immunoprecipitation with anti-FLAG monoclonal
antibody followed by immunoblot detection with an
Figure 3 Pin1 is required for nuclear localization of ADAR2. (A) ADAR2 is mislocalized from the nucleus to the cytoplasm in Pin1
 /  MEF
cells. GFP–ADAR2 immunoﬂuorescence in Pin1
þ/þ and Pin1
 /  MEF cells cotransfected with GluR2 B13 minigene and GFP–ADAR2. DAPI
staining of nuclei (i, iv), GFP ﬂuorescence of cell (ii, v) and merged (iii, vi). (B) Nuclear localization of ADAR2 is restored in Pin1
 /  MEF cells
by transfection of HA–Pin1. GFP–ADAR2 (green) direct and HA–Pin1 (red) indirect immunoﬂuorescence detection in Pin1
 /  MEF cells
cotransfected with GluR2 B13 minigene and (ii) GFP–ADAR2 (green) and (iii) HA–Pin (red). (i) DAPI staining of nuclei. (iv) Merge of all three
images. (C) Nuclear localization of ADAR2 depends on catalytic activity of Pin1. GFP–ADAR2 (green) and HA–Pin1
S67E (red) in Pin1
 /  MEF
cells cotransfected with GluR2 B13 minigene and (ii) GFP–ADAR2 (green) and (iii) HA–Pin1
S67E (red). (i) DAPI staining of nuclei. (iv) Merge of
all three images. All photographs were taken at the same exposure. Scale bar, 10mm. (D) Nucleo-cytoplasmic fractionation. Immunoblot
analysis with anti-FLAG antibody of nuclear and cytoplasmic fractions of Pin1
 /  MEF cells transfected with FLAG–ADAR2 (lanes 1 and 2).
Pin1 was cotransfected with FLAG–ADAR2 in Pin1
 /  MEF cells (lanes 3 and 4). HA–Pin1
S67E was cotransfected in Pin1
 /  MEF cells
(lanes 5 and 6). (Lower panel) Immunoblot of fractionated Pin1
 /  MEF cells with tubulin as a marker for cytoplasmic fraction and HP1a for
nuclear fraction.
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acts best with full-length ADAR2 and with a truncated protein
containing the amino-terminus of ADAR2 (Figure 6B). The
interaction of WWP2 with ADAR2 appears to be weaker with
the site in the deaminase domain or when the amino-termi-
nus of ADAR2 was deleted. We repeated this immunopreci-
pitation with anti-FLAG with mutants of ADAR2 in which the
binding site for WWP2 in the amino-terminus, carboxyl-
terminus or a combination of both binding sites were mu-
tated (Figure 6C). The single mutants decrease the interaction
between ADAR2 and WWP2 whereas the interaction was
completely abolished with the double mutant.
When a cotransfection was performed in HeLa cells with
a constant amount of a plasmid encoding ADAR2 and an
increase in the plasmid expressing WWP2, a drastic
decrease in ADAR2 protein level was observed (Figure 6D).
However, when this experiment was repeated with the double
ADAR2
–PPxY mutant then the level of the mutant protein did
not change as it is no longer a substrate for WWP2. These
experiments demonstrated that WWP2 can interact with
ADAR2 via the PPxY motif present in ADAR2. An increased
expression of WWP2 in HeLa cells resulted in a reciprocal
decrease in ADAR2 levels; however, the protein level of the
ADAR2
–PPxY mutant unable to bind WWP2 remained stable,
demonstrating that WWP2 can cause a decrease in ADAR2
protein levels.
WWP2 poly-ubiquitinates ADAR2
To verify that ADAR2 is indeed poly-ubiquinated by WWP2,
we performed an ubiquitin assay with extract from HEK293T
cells. The cells were transiently cotransfected with ADAR2 or
a mutant where either single or both PPxY motifs in ADAR2
were mutated and a further construct expressing WWP2.
Poly-ubiquitination of ADAR2 was detected in extracts from
cells cotransfected with constructs expressing wild-type
ADAR2 and WWP2 proteins but there was a decrease in
poly-ubiquitination with both the ADAR2
NH2–PPxY and
ADAR2
COOH–PPxY single mutants. Only in the presence of
ADAR2
–PPxY was there a complete loss of poly-ubiquitination
(Figure 7A). Poly-ubiquitination was also observed in the
absence of V5-UBQ as there was sufﬁcient endogenous
ubiquitin in the cell extract (Figure 7A, lane 1).
To demonstrate that the proteosome affected the
stability of ADAR2, a time course was performed in the
presence of the proteosome inhibitor MG132 (Figure 7B).
An increase in the level of ADAR2 was observed; however,
there was not a reciprocal increase in the levels of the
ADAR2
–PPxY mutant. This mutant could no longer bind
WWP2 so the protein level could no longer be regulated by
the proteasome, therefore, the proteosome inhibitor had no
effect on its stability.
To determine if an increase in stability of ADAR2 would
affect its localization, immunoﬂuorescence was performed in
Pin1
þ/þ and Pin1
 /  MEF cells and were transiently trans-
fected with ADAR2
–PPxY. A cytoplasmic accumulation of
ADAR2
–PPxY was evident (Figure 7C). Previously it had
been difﬁcult to observe an accumulation of ADAR2 within
the cytoplasm as the protein was being degraded by WWP2
(Figure 3A). However, as the binding of WWP2 is impaired in
the ADAR2
–PPxY mutant, the cytoplasmic accumulation is
obvious. Nuclear and cytoplasmic fractionation was per-
formed with the ADAR2
–PPxY mutant in MEF wild-type and
Figure 4 Proline 33 of ADAR2 is required for the Pin1 effect on
ADAR2 nuclear localization. (A) Normal localization of ADAR2 and
Pin1. Immunoﬂuorescence of HeLa cells cotransfected with GluR2
B13 minigene, FLAG–ADAR2 and HA–Pin1 stained with (i) DAPI,
(ii) anti-HA–Pin1 (green), (iii) anti-FLAG–ADAR2 (red), (iv) Merge
of DAP1 and FLAG and (v) merge of all three images. (B) Nuclear
localization of ADAR2 depends on Proline 33. Immunoﬂuorescence
of HeLa cells cotransfected with GluR2 B13 minigene, FLAG–
ADAR2
P33A and HA–Pin1 stained with (i) DAPI, (ii) anti-HA–Pin1
(green), (iii) anti-FLAG–ADAR2
P33A (red), (iv) Merge of DAP1 and
FLAG and (v) merge of all three images. All photographs were taken
at the same exposure. Scale bar, 10mm. (C) Nucleo-cytoplasmic
fractionation of wild-type and ADAR
P27A and ADAR2
P33A mutants.
Immunoblot analysis with anti-FLAG antibody of nuclear and
cytoplasmic fractions of HeLa cells transfected with FLAG–ADAR2
(lanes 1 and 2), ADAR
P27A (lanes 3 and 4), ADAR2
P33A (lanes 5 and
6). (Lower panels) Immunoblot of fractionated HeLa cells with
tubulin as a cytoplasmic marker and HP1a as a nuclear marker.
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 /  cells and the results were quantiﬁed (Figure 7D and
E). It is clear that in the absence of Pin1 and if WWP2 cannot
bind to ADAR2, there is a cytoplasmic accumulation of
ADAR2 that is not observed under normal conditions.
Discussion
These data illustrate the complex regulation of ADAR2 by two
proteins with opposing effects; Pin1 is a positive regulator of
ADAR2 whereas WWP2 can bind and cause degradation.
Pin1 and WWP2 regulate other protein such as the large
subunit of RNA pol II and this regulation is conserved from
yeast to mammals (Wu et al, 2001).
When ADAR2 is phosphorylated at the amino-terminus, it
becomes a substrate for the phosphorylation-dependent pro-
lyl-isomerase Pin1. The enzymatic activity of Pin1 is required
for the localization and stability of ADAR2 in the nucleus. In
the absence of Pin1, ADAR2 is unstable and is present in the
cytoplasm. It can then interact with WWP2, an E3 ligase that
results in its poly-ubiquitination and subsequent degradation
by the proteasome (Figure 8). One direct consequence
of this is a reduction in editing of the Q/R site and R/G
sites in GluR2 transcripts. The presence of unedited GluR2
Q
subunit can have dramatic downstream effects as it can
increase the trafﬁcking of GluR2 subunit to the synapse as
well as increasing the permeability of AMPA receptors to
calcium ions.
The function of Pin1 is to isomerize a speciﬁc proline from
the cis to trans conformation or vice versa (Ranganathan et al,
1997; Yaffe et al, 1997). Most biological processes require
proline to be in the trans conformation; however, when the
protein is translated the choice in conformation is dependent
on the surrounding amino acids. If there is a pool of ADAR2
that is not phosphorylated and therefore not a Pin1 substrate,
then this protein may not be fully active. This probably does
occur as ADAR2 is expressed in various mammalian cell lines
such as HeLa and SH-SY5Y but is not very active and for
efﬁcient editing of transcripts, additional ADAR2 must be
transfected. There may be sufﬁcient Pin1 present but the
kinase required for the phosphorylation of the Pin1-binding
site may be limited. This may explain the pool of inactive
ADAR2 that has been observed as it may require phosphor-
ylation and subsequent Pin1 activity. For example in the
undifferentiated NT2 cell line, ADAR2 is well expressed;
however, it requires differentiation of the NT2 to neuronal
cells for efﬁcient editing of GluR2 Q/R; this occurs without
any major change in ADAR2 expression (Lai et al, 1997). The
authors of that study proposed that a post-translational
regulatory mechanism is involved.
In the absence of Pin1, ADAR2 mislocalizes to the cyto-
plasm. It is difﬁcult to detect ADAR2 as it is poly-ubiquiti-
nated by WWP2 in the cytoplasm and degraded. Only when
WWP2 is unable to bind to ADAR2 is high level of cytoplas-
mic accumulation of ADAR2 observed (Figure 7). There are
two binding sites for WWP2 on the ADAR2 protein. The site
Figure 5 Pin1 contributes to stability of ADAR2 protein. (A) Knockdown of Pin1 in HeLa cells destabilizes ADAR2 in a cycloheximide time
course. HeLa cells were transfected with either pSuper LacZ or pSuper Pin1. Cycloheximide (50mg/ml) was added to both and a time course
from 0 to 8h was performed. Cell lysates were analysed by immunoblot and the antibodies used were anti-ADAR2 (top panel), anti-tubulin as a
loading control (middle panel) and Pin1 (bottom panel). (B) Quantiﬁcation of (A). (C) Pin1 knockdown destabilization of FLAG–ADAR2 in SH-
SY5Y neuroblastoma cells. SH-SY5Y cells were cotransfected with FLAG-tagged ADAR2 and a control siRNA or Pin1-speciﬁc siRNA.
Cycloheximide (50mg/ml) was added to both and a time course from 0 to 8h was performed. Cell lysates were analysed by immunoblot
and the antibodies used were anti-FLAG (top panel), anti-Pin1 (middle panel) and GFPas loading control (bottom panel). (D) ADAR2 mutant in
the Pin1-binding site is less stable. SH-SY5Y neuroblastoma cells were transfected with FLAG-tagged ADAR2
S26A/S31A/T32A and cycloheximide
(50mg/ml) was added and a time course was performed from 0 to 8h. Cell lysates were analysed by immunoblot and the antibodies used were
anti-FLAG (top panel), anti-Pin1 (middle panel) and GFP as loading control (bottom panel).
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tant for WWP2 interaction than the site in the deaminase
domain despite the deaminase site being more conserved.
The crystal structure for the deaminase domain of ADAR2
has been solved (Macbeth et al, 2005) and the PPLY amino
acids are on the outside of the protein opposite to the
region that has been proposed to interact with the RNA
(Supplementary Figure S6). Therefore, these amino acids
are easily accessible to WWP2.
The ﬁnding that ADAR2 is regulated by Pin1 and WWP2
opens up new avenues of research. Under normal conditions,
ADAR2 is present within the nucleolus (Desterro et al, 2003;
Sansam et al, 2003). However, once a substrate is transfected
into the cell, it relocates to the nucleus and editing can occur.
One key factor that is missing is the kinase that phosphor-
ylates ADAR2 and instigates this complex regulation. Also,
we would predict from our results both with the ADAR2 triple
mutant (Figure 1) and with ADAR2
P33A (Figure 4) that Thr32
Figure 6 WWP2 interacts with ADAR2. (A) Coimmunoprecipitation of ADAR2 and WWP2 performed with anti-FLAG antibody in HEK293T
cell lysate cotransfected with FLAG–ADAR2 and c-myc–WWP2 or pcD3 empty vector. FLAG–ADAR2 was detected with FLAG antibody. WWP2
input visualized with anti-c-myc antibody (bottom panel). (B) Endogenous WWP2 detected with anti-WWP2 antibody after immunoprecipita-
tion with anti-FLAG antibody from lysates of HEK293Tcells transfected with FLAG-tagged ADAR2, ADAR2
2–305, ADAR2
298–701, ADAR2
D4–72 or
pcD3. Immunoblot of input proteins detected with anti-FLAG antibody (bottom panel). (C) Immunoprecipitation of FLAG–ADAR2 and mutants
with mutations in the amino, carboxyl binding site for WWP2 or a combination of both was performed with anti-FLAG antibody in HEK293
cells. Endogenous WWP2 detected with anti-WWP2 antibody. (Lower panel) Immunoblot of input proteins detected with anti-FLAG antibody.
(D) Immunoblot analysis with anti-FLAG antibody of lysates from HeLa cells cotransfected with FLAG–ADAR2 and increasing amount of
FLAG–WWP2 (0.5, 1, 2.5mg) (upper panel) and this experiment was repeated with the mutant ADAR2
PPxY that is unable to bind to WWP2
(lower panel). The efﬁciency of transfection was normalized to GFP expression. GFP input visualized with anti-GFP antibody is shown below
both panels.
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event. Pin1 interaction requires the binding of ADAR2 to
dsRNA; however, we do not know whether the kinase
phosphorylates ADAR2 in the bound or unbound state.
Also, we do not know what happens after RNA editing has
occurred. Is ADAR2 then a substrate for a phosphatase that
results in its relocation to the nucleolus or is it exported and
degraded? In the absence of Pin1, ADAR2 mislocalizes to the
cytoplasm where it is a substrate for WWP2; however,
the molecular mechanism underlying this mislocalization is
Figure 7 WWP2 is required for ADAR2 ubiquitination and subsequent degradation in the cytoplasm. (A) In vivo ubiquitination assays. FLAG–
ADAR2–His, FLAG–WWP2–His and V5-UBQ were transfected in HEK293T cells followed by puriﬁcation of ubiquitination complexes from
lysates with Ni
2þ-NTA. In lane 1, cotransfection was with FLAG–ADAR2–His, FLAG–WWP2–His. Lane 2, cotransfection was with FLAG–
ADAR2–His, FLAG–WWP2–His and V5-UBQ. Lane 3, cotransfection of FLAG–ADAR2 NH2
–PPxY–His, FLAG–WWP2–His and V5-UBQ. Lane 4,
cotransfection of FLAG–ADAR2 COOH
–PPxY–His, FLAG–WWP2–His and V5-UBQ. Lane 5, cotransfection of FLAG–ADAR2
–PPxY–His (double
mutant), FLAG–WWP2–His and V5-UBQ. Lane 6 is the same as lane 5 without the addition of V5-UBQ and is the negative control. (Middle
panel) Immunoblot of input proteins detected with anti-FLAG antibody. (Lower panel) Immunoblot of V5-UBQ present in the puriﬁed complex
detected with anti-V5 antibody. (B) Immunoblot at 24h following transfection of FLAG–ADAR2 and FLAG–ADAR2
–PPxY with 20mM MG132 to
inhibit protein degradation. The proteasomal inhibitor MG132 was added to both and a time course from 0 to 4.5h was performed in HeLa
cells. Cell lysates were normalized to GFP levels (lower panel). (C) Immunoﬂuorescence of Pin1
þ/þand Pin1
 /  MEF cells cotransfected with
GluR2 and FLAG–ADAR2
–PPxY (double mutant). (i) DAPI staining of nuclei. (ii) Anti-FLAG–ADAR2
–PPxY (red). (iii) Merge of DAP1 and FLAG.
Scale bar, 10mm. All photographs were taken at the same exposure. (D) Nuclear and cytoplasmic fractionation of FLAG–ADAR2
–PPxY in Pin1
þ/
þand Pin1
 /  MEF cells. (Lower panels) Immunoblot of fractionated MEF cells with tubulin as a cytoplasmic marker and HP1a as a nuclear
marker. (E) Quantiﬁcation of (D).
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factors regulate the activity of ADAR2 as this will subse-
quently impinge on the properties of the AMPA receptor.
This report of post-translational regulation of ADAR2
reveals how ADAR2 is highly coordinated and regulated
within the cell as this ultimately controls the calcium perme-
ability and assembly of AMPA receptors. This opposing
regulation by Pin1 and WWP2 is very analogous to that of
the large subunit of yeast RNA polymerase (pol) II where the
yeast orthologue of Pin1; ESS1 binds to the C-terminal
domain and positively regulates RNA pol II transcription
whereas RSP5; a HECT-type E3 ligase similar to WWP2
mediates its ubiquitination and degradation (Wu et al,
2001). This regulation of RNA pol II large subunit by Pin1
and WWP2 is also conserved in mammals (Li et al, 2007; Xu
and Manley, 2007). Therefore, we propose that these two
proteins with opposing effects can act coordinately in the
regulation and stability of other key cellular proteins.
The interaction of ADAR2 with Pin1 may explain why the
Q/R site is edited to 100% in neurons. Pin1 is a key regulator
of many proteins and processes within the cell; however, it is
itself regulated by phosphorylation, which inhibits its activity
(Lu et al, 2002; Lee et al, 2011). We hypothesize that as Pin1 is
the hub of a regulatory network and that transient ischaemia
or other insults lead to reduction in Pin1 activity. A decrease
in ADAR2 activity would then ensue with a subsequent
reduction in editing at the Q/R site in GluR2 transcripts.
This would result in increased calcium permeability of
AMPA receptors that could have major effects depending on
the region of the brain and the presence of calcium-binding
proteins or calcium pumps within the particular neuron. If
calcium-binding proteins are low as in the CA1 pyramidal
neurons, then this could lead to neuronal cell death (Liu and
Zukin, 2007). Therefore, we propose 100% editing of Q/R in
the GluR2 transcript is a ‘quality control’ measure that reﬂects
a healthy neuron. Data from mice support this hypothesis as
when the edited GluR2
R isoform has been knocked-in, the
mice have no apparent phenotype despite a lack of the
unedited isoform (Kask et al, 1998). An explanation why
rats expressing GluR2
R are resistant to forebrain ischaemia in
the vulnerable CA1 pyramidal neurons could be that the
regulatory network from Pin1 to ADAR2 editing the GluR2
Q/R site has been disrupted (Liu et al, 2004). Other experi-
ments are required to rigorously test this hypothesis; how-
ever, if it is correct it will facilitate devising treatments to limit
the neuronal damage associated with forebrain ischaemia.
Materials and methods
A more detailed Materials and methods section is provided in
Supplementary Data.
Mass spectrometry of ADAR2
A measure of 1mg of ADAR2 with FLAG and tetra-histidine epitope
tags was puriﬁed after overexpression in P. pastoris as previously
described (Ring et al, 2004). The puriﬁed protein was denatured in
Novex LDS sample buffer plus 10mM DTT at 651C for 30min and
alkylated with 50mM 4-vinylpyridine for 15min at room tempera-
ture. The protein was separated by SDS–PAGE on a 4–12% MOPS
NUPAGE gel, stained with colloidal Coomasie and digested with
trypsin (5mg/ml) in 50mM ammonium bicarbonate. The phospho-
peptides were enriched with PHOS-select resin (Sigma) and
analysed on a 4700 TOF–TOF mass spectrometer as described
previously (Beullens et al, 2005).
ADAR2 mutagenesis
The pcD3 construct expressing FLAG–ADAR2 has been previously
described (Heale et al, 2009). All mutations were generated with the
QuickChange mutagenesis strategy (Stratagene, La Jolla, CA) and
were sequenced to verify the intended mutations.
Figure 8 Schematic representation of the regulation of ADAR2 by Pin1 and WWP2. ADAR2 can exist as a monomer in the nucleus and has
sequences at its amino-terminus that inhibit enzymatic activity (Macbeth et al, 2004). However, ADAR2 can be phosphorylated by an unknown
kinase either when it is free or bound to dsRNA. ADAR2 is a substrate for Pin1 once it is bound to dsRNA and the active form of ADAR2 is a
dimer (Gallo et al, 2003; Poulsen et al, 2006; Valente and Nishikura, 2007). The mechanism of dimer formation is still unclear. After RNA
editing has occurred, we do not know the fate of ADAR2. However, in the absence of Pin1, ADAR2 mislocalizes to the cytoplasm where it is
poly-ubiquitinated by WWP2 and is degraded by the proteasome.
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26 to A: 50-ctggacaacgtggcccccaaggatggc-30
T
32 to A: 50-tcccccaaggatggcagcgcacctgggcctgg-30
S
26/31 to A: 50-gtcccccaaggatggcgccacacctgggcctggcga-30
S
26/31/T
32 to A: 50-ggacaacgtggctcccaaggatggcgccgcacctgggcctg-30
P
27 to A: 50-ctggacaacgtgtccgccaaggatggcagcaca-30
P
33 to A: 50-cccaaggatggcagcacagctgggcctggcgagggctct-30
ADAR2 was subcloned into pEGFP-C3 with the oligonucleotides:
EcoRI-ADAR2 50-ccggaattctgatggatatagaagatgaagaaaacatgagt-30
ADAR2-SalI (antisense) 50-ccggtcgacctcagggcgtgagtgagaactggtc
ctgctc-30.
WWP2 cloning and mutagenesis
WWP2 was cloned by PCR ampliﬁcation of cDNA clone IMAGE
100008816 (Gene Service) in the expression vector pENTR221 with
the oligonucleotides 50-GGGGACAAGTTTGTACAAAAAAGCAGGCT
CAATGGACTACAAGGACGACGATGACAAAGCATCTGCCAGCTCTAG
CCGGGCA-30 and antisense 50-GGGGACCACTTTGTACAAGAAAGCT
GGGTCCTAATGGTGATGGTGATGGTGCTCCTGTCCAAAGCCTTCGG
TCTC-30 for subsequent gateway cloning (Invitrogen). Similarly,
N- and C-terminal truncations of hADAR2 were constructed by PCR
ampliﬁcation of hADAR2 cDNA into the pGEM T-Easy vector with
the oligonucleotides. 50-GGGGACAAGTTTGTACAAAAAAGCAGGC
TATGGACTACAAGGACGACGATGACAAAGATATAGAAGATGAAGAA
AAC-30 and antisense 50-GGGGACCACTTTGTACAAGAAAGCTG
GGTCTAATGGTGATGGTGATGGTGTGGCGTCTGATCCAAGTCCAA-30
primers were used to produce a construct encoding only the
N-terminal portion of hADAR2.
To produce a construct encoding the C-terminal portion of
hADAR2 with the oligonucleotides 50-GGGGACAAGTTTGTA
CAAAAAAGCAGGCTATGGACTACAAGGACGACGATGACAAATTGC
ACTTGGATCAGACGCCA-30 and antisense 50-GGGGACCACTTTGTAC
AAGAAAGCTGGGTCTAATGGTGATGGTGATGGTGGGGCGTGAGTGA
GAACTGGTC-30 were used. All primers were designed to incorpo-
rate 50 FLAG (bold) and 30 HIS epitope tags (underlined) at either
end of the respective ORF, as well as the att recombination sites
required for gateway cloning (italics). The puriﬁed PCR products
were cloned by site-speciﬁc recombination into the donor vector
pDONR221 to generate an entry clone. The entry clone was used in
a second site-speciﬁc recombination reaction with the modiﬁed
destination vector pcD3 (origin pcDNA3) to generate the expression
clone (following the standard protocol, as described by Invitrogen).
To generate FLAG–ADAR2 NH2
–PPxY (PPFY to AAFA) and FLAG–
ADAR2 COOH2
–PPxY (PPLY to AALA) the following oligonucleotides
were used:
FLAG–ADAR2
NH2–PPxY 50-gacaaggcggcagcatttgccgtgggctcc-30 and
for FLAG–ADAR2
COOH–PPxY 50-gaggacctggcagctctcgccaccctcaac-30
Immunoblot analysis, immunoprecipitation and GST pull
down
Expression and puriﬁcation of the GST-tagged proteins were
performed as described (Buratti and Baralle, 2001). Immunopreci-
pitation was performed as described (Rustighi et al, 2009).
Immunoblot analysis was performed with primary antibodies:
mouse a-FLAG 1:3000 (Sigma), mouse a-HA 1:1000 (Sigma), mouse
a-MPM-2 1:1000 (Upstate Cell Signaling) (Davis et al, 1983) mouse
a-Pin1 1:500 (G-8) (Santa Cruz Biotechnology, Santa Cruz, CA)
rabbit a-ADAR2 1:1000 (Sigma), mouse a-GST 1:5000 dilution
(Amersham Pharmacia), overnight at 41C, followed by an 1-h
incubation with the appropriate secondary antibody (Dako).
Ubiquitination assay and proteasome-mediated degradation
analysis
Cells were cotransfected with the indicated constructs at the
following ratios: FLAG–ADAR2 and FLAG–ADAR2
–PPxY 1mg,
FLAG–WWP2 and FLAG–WWP2 (C/A) 4mg, V5-UBA 1mg. After
24h, cells were harvested and lysed under denaturing conditions,
and ubiquitinated proteins were puriﬁed with Ni
2þ-NTA agarose
beads (QIAGEN) as described previously (Rodriguez et al, 1999).
The cells in Figure 7A were incubated for 4.5h with 20mM MG132
(Calbiochem), 20mM MG5 (Sigma) prior to lysis.
Cell lines, transfection conditions and RNA extraction
MEF cells were cultured in a Hypoxic incubator, 10% CO2,3 %O 2
(Thermo Scientiﬁc HeraCell 150i) (Parrinello et al, 2003). Total RNA
was extracted from cells with Trizol reagent (Invitrogen) and treated
with Turbo DNA-free DNAseI beads (Ambion). cDNA synthesis was
performed with random-hexamer primers. PCR of the GluR2 B13
minigene was performed with primer, 50-atggaagagaaacacaaagt-30
that anneals to exon 11 and antisense primer 50-gaatgataggaacct
tctgc-30 that anneals to intron 11 (Higuchi et al, 1993). PCRs
conditions were 941C for 3min, followed by 28 cycles of: 941C for
30s, 541C for 30s, 721C for 45s and 721C for 7min. For endogenous
GluR2 transcript, 1mg of DNAse-treated total RNA was used for
cDNA synthesis and RT–PCR was performed with SuperscriptTMIII
One step RT–PCR System (Invitrogen), was performed with primer,
50-atggaagagaaacacaaagt-30 and the antisense primer 50-ttccctttggac
ttccgcac-30 that anneals to exon 13.
RNAi knockdown
siRNA or pSUPER transfections were performed in HeLa and SH-
SY5S cells with Lipofectamine 2000 reagent (Invitrogen). Both siRNA
against GAPDH and smart Pool of siRNAs against Pin1 (LPIN1,
Dharmacon Thermo Scientiﬁc) were added to a ﬁnal concentration of
100 nM. The pSUPERPin1 and pSUPERLacZ were used as siRNA
controls as previously described (Rustighi et al, 2009).
Indirect immunoﬂuorescence
Cells were plated on sterile cover-slips in six-well plates at
2.5 10
5cells/well and grown overnight before transient transfec-
tion of expression constructs with Fugene 6 transfection reagent
(Roche). Indirect immunoﬂuorescence was performed as previously
(Ayala et al, 2008).
Preparation of cytoplasmic and nuclear extracts
Cytoplasmic and nuclear fractionation was performed with Pro-
teoExtract Subcellular Proteome Extraction Kit (Merck) according to
the manufacturer’s instructions. Quantiﬁcation of cytoplasmic and
nuclear fractionation was performed with the IMAGEQUANT/TL
(GE Heathcare Life Science).
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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